-
Most Recent
Search Results
240 results for stri
AI Forced Two Utilities to Merge… Here’s How to Profit
In today’s Smart Money, I’ll explain the details of a historic merger, and what it represents: AI is turning electricity into a high-growth industry. And…
Is Sirius XM Stock a Buy? Only If You Like Watching Paint Dry
With strong earnings, an increase in subscribers and a great audience demographic, SIRI may seem like a buy — but that’s not the whole story.
Recent Apple Patents Point the Way to the Future
“Recent Apple Patents Point the Way to the Future,” the last in a series of three stories highlighting Apple’s approach to intellectual property.
Here’s Why Everyone’s Wrong About What’s About to Happen at the Fed
In today’s Market 360, I’ll explain the connection between Bessent and Warsh – and why I think it’s good news for investors. I’ll also give…
Apple Inc.’s (AAPL) Siri Speaker Will Try to Topple the Market
You may not be able to buy a Siri speaker until fall, but Apple’s answer to the Amazon Echo reportedly focuses on sound quality.
The Market Now Expects a Rate Hike. Louis Disagrees
From two cuts to a hike in five months… why Louis says the market is misreading this… the Bessent-Warsh playbook… how to be positioned before…
Apple Inc. Is Giving Siri a Helping Hand (AAPL)
Apple (AAPL) will try to keep Siri ahead of its competitors like Cortana and Alexa by hiring a new director of AI research.
How I Found a 600% Winner Before Wall Street Caught On
In today’s Market 360, I want to tell you how my system found this company before Wall Street did, what it actually does – and…
Sirius XM – Investors Should Start to Tune Into SIRI Stock
Trading vehicle or not, recent Sirius XM earnings tell a story of a legit company with future upside. Don’t shy away from SIRI stock.
Apple Inc. (AAPL) Puts the Sword to iPhone Issues
Apple (AAPL) is trying to put out iPhone 6 series fires on multiple fronts, including an increasingly messy situation in China.
5 of Pharma’s Most Disastrous Drug Approvals
These five exciting drug approvals now serve as warning stories about the potential pitfalls for investors trying to time a pharma stock buy.
LIFE Stock: What Is the Clinical Trial News Sending aTyr Pharma Soaring?
Today, some news of positive clinical trial results for one of aTry’s leading drug candidates has sent LIFE stock surging.
New Taco Bell ‘Forbidden’ Menu Will Feature Black Rice
Taco Bell (YUM) is trying out a new series of products as part of the company’s Forbidden Menu, which includes black rice and more weirdness.
Don’t Trade Oil Headlines. Watch These Two Signals.
Oil volatility is rising. Crack spreads and backwardation are flashing signals that could point to refiner-stock opportunities.
The AI Story Is Changing – And So Will the Market Leaders
In today’s Market 360, I want to explain what AI agents really are, how they emerged so quickly and why they could become far more…
How to Profit From the Coming Oil Shock Before Wall Street Does
In today’s Friday Digest takeover, veteran trader Jonathan Rose highlights the two market indicators he watches during periods of energy stress – and explains why…
Why Short-Squeeze Candidate STR Stock Is One to Watch
It’s fine to try a short-term trade with STR stock, but the biggest gains could come to Sitio Royalties’ patient buy-and-hold investors.
Wall Street Let AI Pick Stocks and Here Is What Happened
Longtime Digest readers know how bullish we are on the AI Megatrend. We’ve tried hard to keep our readers in profitable trades involving semiconductors, AI…
The Biggest AI Story You Missed
Claude’s Mythos causes cybersecurity stocks to tank… the quantum threat to online security is coming fast… how Jonathan Rose is playing it… has the energy…
Here’s How to Profit From the Oil Signals Most Traders Miss
To explain how to navigate today’s oil market, I’ve invited my colleague Jonathan Rose to discuss the two specific market signals investors should watch out…
The Story’s Not Changing Anytime Soon for Clover Stock
As fixing its profitability problem remains a work-in-progress, and as a market downturn will likely send it plummeting once more, avoiding CLOV stock is still…
9 – 10 of 240 results
